Clinical Trials in Denver

Showing 7261-7280 of 13,773 trials

A Study of PTR-01 in Recessive Dystrophic Epidermolysis Bullosa

NCT04599881

Protocol PTR-01-002 is a 3-part Phase 2, open-label study of PTR-01. While new patients will be enrolled, priority will be given to patients that satisfactorily completed study PTR-01-001.

Recessive Dystrophic Epidermolysis Bullosa

Phoenix Tissue Repair, Inc.6 participantsStarted Oct 2020

Redwood City, California, United States • Aurora, Colorado, United States

TERMINATEDNA8.4 miles

Pharmacogenetic Prediction of Metoprolol Effectiveness

NCT02293096

The investigators will prospectively follow a population of patients with uncontrolled high blood pressure beginning metoprolol succinate therapy to determine the drug effect in an observational clinical trial. The investigators will determine each individual's genotype for both CYP2D6 and Adrenoceptor Beta 1 (ADRB1). Metabolomic markers will be identified to determine if specific metabolites are associated with drug response. The investigators' overall objective is to determine if genetics predicts metoprolol succinate response better than clinical factors such as age, race, body mass index, dose, and medication co-ingestion.

Hypertension

University of Colorado, Denver462 participantsStarted Sep 2014

Aurora, Colorado, United States

A Study of PTR-01 in Recessive Dystrophic Epidermolysis Bullosa

Pharmacogenetic Prediction of Metoprolol Effectiveness

Find Trials by Condition in Denver

Bromocriptine Quick Release (BCQR) as Adjunct Therapy in Type 1 Diabetes

Insulin Pump to Multiple Daily Injection Transition Clinical Trial

Treatment of Tracheostomy Granulomas

Addressing Anxiety and Stress for Healthier Eating in Teens

A Study Evaluating Pertuzumab (Perjeta) Combined With Trastuzumab (Herceptin) and Standard Anthracycline-based Chemotherapy in Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Locally Advanced, Inflammatory, or Early-stage Breast Cancer

Study to Investigate Efficacy and Safety of PF-04965842 in Subjects Aged 12 Years and Over With Moderate to Severe Atopic Dermatitis With the Option of Rescue Treatment in Flaring Subjects

Dose Range Study of CD5789 in Acne Vulgaris

OptiMesh® for Lumbar Interbody Fusion Trial (OLIF)

Phase 2B Efficacy/Safety of Ornithine Phenylacetate in Hospitalized Cirrhotic Patients With Hepatic Encephalopathy (STOP-HE)

A Safety and Efficacy Comparison of BLI4700 Bowel Preparation Versus an FDA-approved Comparator in Adult Subjects Prior to Colonoscopy

Effects and Safety of OPK-88004 Doses in Men With Signs and Symptoms of Benign Prostatic Hyperplasia (BPH)

Stress Management for Cancer Patients: How Well Does it Work? (C2H-D)

Safety and Efficacy Study of EXC 001 to Improve the Appearance of Scars From Prior Breast Surgery

A Study of MPT-0118 in Subjects With Advanced or Metastatic Refractory Solid Tumors

A Study of Galunisertib (LY2157299) in Combination With Nivolumab in Advanced Refractory Solid Tumors and in Recurrent or Refractory NSCLC, or Hepatocellular Carcinoma

Sertraline Compared With Hypericum Perforatum (St.John's Wort) in Treating Depression

GARNET™ Filter (GARNET Device) IDE Used in Chronic Hemodialysis Patients With a Bloodstream Infection

Study of Nolasiban to Increase Pregnancy Rates in Women Undergoing IVF